Wealth Preservation Advisors’s Novartis NVS Stock Holding History
Bought
Maintained
Sold
Other funds holding NVS
Wealth Preservation Advisors's NVS Position: Q1 2026 in Review
Wealth Preservation Advisors sold out of Novartis (NVS) in Q1 2026, closing a stake of 39 shares — an estimated $5.38K sold.
Wealth Preservation Advisors first reported a position in NVS in Q2 2025 and held it in 3 quarters. The position peaked at $5.69K in Q2 2025. 1,601 funds tracked by Wall St. Rank hold NVS as of Q1 2026.
- Wealth Preservation Advisors reported no remaining Novartis position as of Q1 2026 after selling out during the quarter.
- Wealth Preservation Advisors sold 39 Novartis shares in Q1 2026, an estimated $5.38K.
- Wealth Preservation Advisors first reported a position in Novartis in Q2 2025 and held it in 3 quarters.
- Wealth Preservation Advisors's Novartis position peaked at $5.69K in Q2 2025.
- 1,601 funds tracked by Wall St. Rank held Novartis as of Q1 2026.
Based on Wealth Preservation Advisors's 13F filing for Q1 2026, filed 15 May 2026.